The Mounjaro September Price Increase — What Changed and What It Means for You

You checked the price you were paying and it had gone up, here's why

In late August 2025, Eli Lilly confirmed it was revising Mounjaro's UK list price with effect from 1 September 2025. The change was steep at the higher doses: a single four-week pen at the 15mg strength moved from roughly £122 to roughly £330 on the manufacturer's list. Lower strengths saw proportionally similar increases, though exact figures varied. For anyone already titrating through the dose schedule, the timing felt abrupt. For people weighing up whether to start, it changed the maths entirely, and our September 2025 price increase page sets out exactly what shifted and why.

The list price is what Lilly charges the supply chain. Private providers set their own retail prices on top (covering dispensing, clinical oversight, prescriptions and delivery) so what you actually pay reflects both the manufacturer's increase and the provider's own cost structure. The detail of how that September increase feeds through to private prices is covered more fully in our breakdown of the broader price change picture.

One thing worth knowing: Mounjaro treatment starts at 2.5mg (the starter dose exists to let your system settle, not to produce the main therapeutic effect), so the cost at the beginning of treatment is lower than the cost once you reach a maintenance dose. That matters when you're comparing monthly figures between providers, because the quoted price often reflects a specific strength.

What a headline price usually leaves out

Across the private weight-loss market, the number displayed on a provider's website is frequently the medicine cost alone. A consultation fee may be charged separately. A prescription fee (sometimes described as an admin charge) can appear at checkout. Delivery costs vary. Aftercare, dose-change reviews and any follow-up clinical contact are commonly billed as add-ons, or simply not offered.

None of that is mentioned when someone searches for Mounjaro prices in September and lands on a figure that looks attractively low. The full cost of private Mounjaro treatment only becomes clear once you've worked through a provider's checkout. For a prescription medicine dispensed through a clinical pathway, the question isn't just what the pen costs, it's what the complete package costs, and what that package actually includes.

Our prescribers field questions about this regularly. People arrive having paid a low headline price elsewhere and discovered the aftercare they needed wasn't part of the deal. Worth knowing before you commit.

Where nume sits on price, and why we're upfront about it

We're not the cheapest option, and we've made a deliberate choice not to be. One price covers everything: your free initial consultation, the clinical assessment by a GPhC-registered prescriber, your prescription, the medicine, and free next-working-day delivery via DPD, tracked, in plain packaging. The pen arrives in a box that gives nothing away about its contents; what's inside is your business. No consultation fee lands at checkout. No delivery charge. No subscription that auto-renews before you've had a chance to be reviewed again.

Every repeat order goes back in front of a prescriber before it's dispensed. That's not a marketing point, it's a GPhC-aligned clinical standard, and it means the price you pay includes a real clinical decision, not just a fulfilment step. Current treatment pricing is shown on our weight-loss treatments page. We don't publish per-pen prices in articles because they shift with dose and with Lilly's list-price decisions; the treatments page is always current.

If you want to understand the broader context of what drove the September price rise, or compare how the increase affected different strengths, those pages go into more depth.

For a prescription medicine, cost isn't the only thing to get right

The September increase made affordability a genuine concern for many people, that's real, and it's fair to say so. At the same time, a lower price on a prescription medicine isn't automatically good news. The MHRA has issued clear warnings about counterfeit weight-loss pens sold through social media and unverified online sellers: fake pens have contained insulin rather than tirzepatide, and the MHRA's Yellow Card scheme exists partly so patients can report suspect products. A price that sits well below the post-September market rate is worth treating as a flag rather than a bargain.

The safe route to Mounjaro in the UK is a prescription issued after clinical assessment, dispensed by a pharmacy you can verify. You can check any registered pharmacy (including ours) on the GPhC register (our premises registration number is 9012878). If a seller is offering these medicines without requiring a clinical assessment, that's a compliance problem, not a deal. For a full picture of how Mounjaro works and who it's suitable for, our main tirzepatide guide covers the clinical detail. When you're ready, speak to our prescribers, the consultation is free and reviewed the same day.